AMD 2023 Mar: Avacincaptad Pegol for Geographic Atrophy: GATHER1 18-Month Results

from Eye Research Deep Dive: Doctopus the Octometrist · host Dr Michael Nelson, OD FAAO

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialPatel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 Dec;37(17):3551-3557. doi: 10.1038/s41433-023-02497-w. Epub 2023 Mar 24. Erratum in: Eye (Lond). 2023 Dec;37(17):3705. doi: 10.1038/s41433-023-02548-2. PMID: 36964259; PMCID: PMC10686386.https://pmc.ncbi.nlm.nih.gov/articles/PMC10686386/pdf/41433_2023_Article_2497.pdf

Episode metadata supplied by the publisher feed · Published Nov 19, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

AMD 2023 Mar: Avacincaptad Pegol for Geographic Atrophy: GATHER1 18-Month Results

0:00 12:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Eye Research Deep Dive: Doctopus the Octometrist?

This episode is 12 minutes long.

When was this Eye Research Deep Dive: Doctopus the Octometrist episode published?

This episode was published on November 19, 2025.

Can I download this Eye Research Deep Dive: Doctopus the Octometrist episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!